Glenmark Pharmaceuticals has informed that it has attached media release on 22nd February 2021 titled ‘Glenmark’s Ryaltris®-innovative single nasal spray, ready to market in Russia’ which is self?explanatory.
The above information is a part of company’s filings submitted to BSE.